
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
View the latest job opportunities, brought to you by Contemporary Pediatrics.
J M, LLC
Northern Berkshire Pediatrics
Pediatric Clinic
Riverside Pediatrics
Saltzer Medical Group
San Juan Regional Medical Center






